Pulmonary hypertension surveillance United States, 2001 to 2010

Chest

Volumn 146, Issue 2, 2014, Pages 476-495

  George, Mary G ^a   Schieb, Linda J ^a   Ayala, Carma ^a   Talwalkar, Anjali ^b   Levant, Shaleah ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; AORTA STENOSIS; ARTICLE; AUTOIMMUNE DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHILD; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH CERTIFICATE; DISEASE REGISTRY; DISEASE SURVEILLANCE; EMPHYSEMA; ETHNIC DIFFERENCE; FEMALE; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; ICD-10; ICD-9-CM; INFLUENZA; INTERSTITIAL LUNG DISEASE; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; SEX DIFFERENCE; TREND STUDY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FORECASTING; HOSPITALIZATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MORBIDITY; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES;

EID: 84905667076     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0527     Document Type: Article

References (34)

1. Aronson JK. Rare diseases and orphan drugs. Br J Clin Pharmacol. 2006;61(3):243-245. (Pubitemid 43382622)
2. Hyduk A, Croft JB, Ayala C, Zheng K, Zheng ZJ, Mensah GA. Pulmonary hypertension surveillance-United States, 1980-2002. MMWR Surveill Summ. 2005;54(5):1-28.
3. Brown LM, Chen H, Halpern S, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 2011;140(1):19-26.
4. Deaño RC, Glassner-Kolmin C, Rubenfire M, et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med. 2013;173(10):887-893.
5. Badesch DB, Champion HC, Sanchez MAG, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(suppl 1):S55-S66.
6. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(suppl 1):S43-S54.
7. Thenappan T, Ryan JJ, Archer SL. Evolving epidemiology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186(8):707-709.
8. Humbert M, Simonneau G, Rubin LJ. A decade of achievement in pulmonary hypertension. Eur Respir Rev. 2011;20(122):215-217.
9. Peacock A. Pulmonary hypertension. E ur Respir Rev. 2013;22(127):20-25.
10. McGoon MD, Krichman A, Farber HW, et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc. 2008;83(8):923-931.
11. Centers for Disease Control and Prevention, National Center for Health Statistics. National Hospital Discharge Survey. Centers for Disease Control and Prevention website. http://www.cdc.gov/nchs/nhds.htm. Accessed March 31, 2014.
12. Centers for Disease Control and Prevention, National Center for Health Statistics. About underlying cause of death 1999-2010. CDC WONDER website. http://wonder.cdc.gov/ucd-icd10.html. Accessed December 22, 2013.
13. Link J, Glazer C, Torres F, Chin K. International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies. Chest. 2011;139(3):497-504.
14. Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2. 2008;(148):1-13.
15. Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National Hospital Discharge Survey: 2007 summary. National Health Statistics Reports; No 29. Hyattsville, MD: National Center for Health Statistics. http://www.cdc.gov/nchs/data/nhsr/nhsr029.pdf. Published 2010. Accessed December 15, 2013.
16. Klein RJ, Schoenborn CA. Age Adjustment Using the 2000 Projected US Population. Healthy People 2010 Statistics Notes, No. 20. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2001.
17. Gillum BS, Graves EJ, Kozak LJ. Trends in hospitalization: United States, 1988-92. National Center for Health Statistics website. http://www.cdc.gov/ nchs/data/series/sr-13/sr13-124.pdf. Published 1996. Accessed December15, 2013.
18. Frost AE, Badesch DB, Barst RJ, et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. Chest. 2011;139(1):128-137.
19. Lilienfeld DE, Rubin LJ. Mortality from primary pulmonary hypertension in the United States, 1979-1996. Chest. 2000;117(3):796-800. (Pubitemid 30152223)
20. Davis KK, Lilienfeld DE, Doyle RL. Increased mortality in African Americans with idiopathic pulmonary arterial hypertension. J Natl Med Assoc. 2008;100(1):69-72. (Pubitemid 351224259)
21. Yaqub A, Chung L. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep. 2013;15(1):302.
22. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886-895. (Pubitemid 38252536)
23. O'Callaghan DS, Humbert M. A critical analysis of survival in pulmonary arterial hypertension. Eur Respir Rev. 2012;21(125):218-222.
24. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387.
25. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest. 2003;123(2):344-350. (Pubitemid 36269414)
26. Austin ED. Gender, sex hormones, and pulmonary arterial hypertension. Advances in Pulmonary Hypertension. 2011;10(3):160-166.
27. Kawut SM, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol. 2005;95(2):199-203. (Pubitemid 40092084)
28. Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013;144(1):169-176.
29. Bolignano D, Rastelli S, Agarwal R, et al. Pulmonary hypertension in CKD. Am J Kidney Dis. 2013;61(4):612-622.
30. Murphy SL, Xu JQ, Kochanek KD. Deaths: final data for 2010. Hyattsville, MD: National Center for Health Statistics. http://www.cdc.gov/copd/data.htm. Published 2013. Accessed December 9, 2013.
31. Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention. Interactive Atlas of Heart Disease and Stroke. Centers for Disease Control and Prevention website. http://www.cdc.gov/dhdsp/maps. Accessed December 22, 2013.
32. Ling Y, Johnson MK, Kiely DG, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186(8):790-796.
33. Shimony A, Fox BD, Afilalo J, Rudski LG, Hirsch A, Langleben D. Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival. Lung. 2012;190(6):645-649.
34. Merrill CT, Nagamine M, Elixhauser A. Hospital stays involving chronic pulmonary heart disease, 2005. HCUP Statistical Brief No. 43. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb43.pdf. Published December 2007. Accessed December 15, 2013.